Patents by Inventor Jerome Garin

Jerome Garin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bladder cancer biomarker proteins
    Patent number: 11536724
    Abstract: The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.
    Type: Grant
    Filed: December 23, 2016
    Date of Patent: December 27, 2022
    Assignees: POLYQUANT GMBH, COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES, BIOMEDICAL RESEARCH FOUNDATION OF THE ACADEMY OF ATHENS, LUXEMBOURG INSTITUTE OF HEALTH, INSTITUT CURIE, ASSISTANCE PUBLIQUE—HOPITAUX DE PARIS, FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III, CNIO
    Inventors: Jerome Garin, Christophe Masselon, Antonia Vlahou, Manousos Makrydakis, Ieronimos Zoidakis, Bruno Domon, Elodie Duriez, Aurelie Kamoun, Francois Radvanyi, Yves Allory, Nuria Malats Riera, Mirari Marquez Cid, Magali Court
  • Process for in vitro diagnosis of hepatic disorders
    Patent number: 11221341
    Abstract: Process for in vitro diagnosis and/or monitoring and/or prognosis and/or theranosis of hepatic disorders from a biological sample originating from a subject, in which process the presence and/or the concentration of the marker ADH1B (SEQ ID NO.2) and/or the presence and/or the concentration of the combination of the markers ADH1B (SEQ ID NO.2) and ADH1A (SEQ ID NO.1) is determined.
    Type: Grant
    Filed: January 16, 2017
    Date of Patent: January 11, 2022
    Assignees: Commissariat a 1'Energie Atomique et aux Energies Alternatives, Centre Hospitalier Universitaire, Universite Grenoble Alpes, Institut National de la Sante et de la Recherche Medicale, Universite Paris Sud
    Inventors: Virginie Brun, Jérôme Garin, Christophe Bruley, Jamila Faivre, Jean-Pierre Zarski, Vincent Leroy
  • Process for In Vitro Diagnosis of Hepatic Disorders
    Publication number: 20190033324
    Abstract: Process for in vitro diagnosis and/or monitoring and/or prognosis and/or theranosis of hepatic disorders from a biological sample originating from a subject, in which process the presence and/or the concentration of the marker ADH1B (SEQ ID NO.2) and/or the presence and/or the concentration of the combination of the markers ADH1B (SEQ ID NO.2) and ADH1A(SEQ ID NO.1) is determined.
    Type: Application
    Filed: January 16, 2017
    Publication date: January 31, 2019
    Applicants: Commissariat a l'Energie Atomique et aux Energies Alternatives, Centre Hospitalier Universitaire, Universite Grenoble Alpes, INSERM, Universite Paris Sud
    Inventors: Virginie Brun, Jérôme Garin, Christophe Bruley, Jamila Faivre, Jean-Pierre Zarski, Vincent Leroy
  • BLADDER CANCER BIOMARKER PROTEINS
    Publication number: 20180372754
    Abstract: The invention relates to a collection of signature peptides representing at least 10 proteins for use in cancer diagnosis and/or prognosis, to an artificial protein comprising signature peptides representing at least 10 proteins and to a nucleic acid construct encoding for such an artificial protein. The invention further relates to a collection of at least 10 proteins for use in cancer diagnosis and/or prognosis. Additionally, the invention relates to a method for cancer diagnosis and/or prognosis comprising the step of analyzing at least 10 proteins in a urine sample of a subject. Finally, the invention relates to an immunoassay product comprising antibodies for detecting at least 10 proteins.
    Type: Application
    Filed: December 23, 2016
    Publication date: December 27, 2018
    Inventors: Jerome GARIN, Christophe MASSELON, Antonia VLAHOU, Manousos MAKRYDAKIS, Ieronimos ZOIDAKIS, Bruno DOMON, Elodie DURIEZ, Aurelie KAMOUN, Francois RADVANYI, Yves ALLORY, Nuria MALATS RIERA, Mirari MARQUEZ CID, Magali COURT
  • Method for absolute quantification of polypeptides
    Patent number: 8871688
    Abstract: The present invention relates to a method for absolute quantification of polypeptides.
    Type: Grant
    Filed: June 2, 2008
    Date of Patent: October 28, 2014
    Assignees: INSERM (Institut National de la Sante et de la Recherche Medicale), Commissariat a l'Energie Atomique
    Inventors: Virginie Brun, Alain Dupuis, Jerome Garin
  • Method for Absolute Quantification of Polypeptides
    Publication number: 20100173786
    Abstract: The present invention relates to a method for absolute quantification of polypeptides.
    Type: Application
    Filed: June 2, 2008
    Publication date: July 8, 2010
    Applicant: COMMISSARIAT A L'ENERGIE ATOMIQUE
    Inventors: Virginie Brun, Alain Dupuis, Jerome Garin
  • Plastidial targeting peptide
    Patent number: 7741073
    Abstract: The invention relates to a non-cleavable, plastidial targeting polypeptide derived from a protein from the inner membrane of plant chloroplasts. Said peptide is particularly suitable for importing proteins of interest in plants.
    Type: Grant
    Filed: April 15, 2008
    Date of Patent: June 22, 2010
    Assignee: Genoplante-Valor
    Inventors: Stephane Miras, Daniel Salvi, Norbert Rolland, Jacques Joyard, Myriam Ferro, Jerome Garin, Didier Grunwald
  • PLASTIDIAL TARGETING PEPTIDE
    Publication number: 20080263728
    Abstract: The invention relates to a non-cleavable, plastidial targeting polypeptide derived from a protein from the inner membrane of plant chloroplasts. Said peptide is particularly suitable for importing proteins of interest in plants.
    Type: Application
    Filed: April 15, 2008
    Publication date: October 23, 2008
    Applicant: GENOPLANTE-VALOR
    Inventors: Stephane MIRAS, Daniel SALVI, Norbert ROLLAND, Jacques JOYARD, Myriam FERRO, Jerome GARIN, Didier GRUNWALD
  • Plastidial-targeting peptide
    Patent number: 7414025
    Abstract: The invention relates to a non-cleavable, plastidial targeting polypeptide derived from a protein from the inner membrane of plant chloroplasts. Said peptide is particularly suitable for importing proteins of interest in plasts.
    Type: Grant
    Filed: June 19, 2003
    Date of Patent: August 19, 2008
    Assignee: Genoplante-Valor
    Inventors: Stéphane Miras, Daniel Salvi, Norbert Rolland, Jacques Joyard, Myriam Ferro, Jérome Garin, Didier Grunwald
  • Plastidial-targeting peptide
    Publication number: 20060059587
    Abstract: The invention relates to a non-cleavable, plastidial targeting polypeptide derived from a protein from the inner membrane of plant chloroplasts. Said peptide is particularly suitable for importing proteins of interest in plasts.
    Type: Application
    Filed: June 19, 2003
    Publication date: March 16, 2006
    Applicant: gENOPLANTE-VALOR
    Inventors: Stephane Miras, Daniel Salvi, Norbert Rolland, Jacques Joyard, Myriam Ferro, Jerome Garin, Didier Grunwald